Circular RNA CHST15 Sponges miR-155-5p and miR-194-5p to Promote the Immune Escape of Lung Cancer Cells Mediated by PD-L1
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Circular RNA CHST15 Sponges miR-155-5p and miR-194-5p to Promote the Immune Escape of Lung Cancer Cells Mediated by PD-L1
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-11
DOI
10.3389/fonc.2021.595609
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Construction of a circRNA-miRNA-mRNA network based on competitive endogenous RNA reveals the function of circRNAs in osteosarcoma
- (2020) Yu Qiu et al. Cancer Cell International
- Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients
- (2020) Daan P. Hurkmans et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Advances in Research on the circRNA-miRNA-mRNA Network in Coronary Heart Disease Treated with Traditional Chinese Medicine
- (2020) Fei Lin et al. Evidence-based Complementary and Alternative Medicine
- Hsa_circ_RNA_0011780 Represses the Proliferation and Metastasis of Non-Small Cell Lung Cancer by Decreasing FBXW7 via Targeting miR-544a
- (2020) Yong Liu et al. OncoTargets and Therapy
- Knockdown of circ-ABCB10 promotes sensitivity of lung cancer cells to cisplatin via miR-556-3p/AK4 axis
- (2020) Zhihui Wu et al. BMC Pulmonary Medicine
- A circRNA derived from linear HIPK3 relieves the neuronal cell apoptosis in spinal cord injury via ceRNA pattern
- (2020) Jingwei Zhao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Circ_0072083 interference enhances growth-inhibiting effects of cisplatin in non-small-cell lung cancer cells via miR-545-3p/CBLL1 axis
- (2020) Huiping Li et al. Cancer Cell International
- Detection of miR-155-5p and imaging lung cancer for early diagnosis: in vitro and in vivo study
- (2020) Hai-Zhen Zhu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Signaling pathways and clinical application of RASSF1A and SHOX2 in lung cancer
- (2020) Nanhong Li et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Downregulation of miR-194-5p induces paclitaxel resistance in ovarian cancer cells by altering MDM2 expression
- (2019) Koji Nakamura et al. Oncotarget
- Bronchial Artery Embolization for Hemoptysis in Primary Lung Cancer: A Retrospective Review of 84 Patients
- (2019) Kichang Han et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- PD-1/PD-L1 pathway: Basic biology and role in cancer immunotherapy
- (2019) Arash Salmaninejad et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Biological therapies in lung cancer treatment: using our immune system as an ally to defeat the malignancy
- (2019) Martyna Filipska et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- miR‐155‐5p and miR‐760 mediate radiation therapy suppressed malignancy of non‐small cell lung cancer cells
- (2019) Lin Zhu et al. BIOFACTORS
- Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
- (2019) Mauro Poggio et al. CELL
- Lung Cancer
- (2019) Faria Nasim et al. MEDICAL CLINICS OF NORTH AMERICA
- MiR-155-5p accelerates the metastasis of cervical cancer cell via targeting TP53INP1
- (2019) Ning Li et al. OncoTargets and Therapy
- Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy for non-small cell lung cancer
- (2019) Yu-Tao Liu et al. Journal of Thoracic Disease
- Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer
- (2019) Dong Ha Kim et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Circ_ZNF124 promotes non-small cell lung cancer progression by abolishing miR-337-3p mediated downregulation of JAK2/STAT3 signaling pathway
- (2019) Qianping Li et al. Cancer Cell International
- EGFR-TKI resistance promotes immune escape in lung cancer via increased PD-L1 expression
- (2019) Shunli Peng et al. Molecular Cancer
- MiR-155-5p inhibits PDK1 and promotes autophagy via the mTOR pathway in cervical cancer
- (2018) Fang Wang et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- CD4+ and CD8+ T Cells Exert Regulatory Properties During Experimental Acute Aristolochic Acid Nephropathy
- (2018) Thomas Baudoux et al. Scientific Reports
- Circular RNA hsa_circ_0052112 promotes cell migration and invasion by acting as sponge for miR-125a-5p in breast cancer
- (2018) He-da Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- The downregulation of hsa_circ_0012919, sponge for miR-125a-3p, contributes to DNA methylation of CD11a and CD70 in CD4+T cells of SLE
- (2018) Chengzhong Zhang et al. CLINICAL SCIENCE
- Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer
- (2018) Longqiang Wang et al. Molecular Cancer
- The SOX2OT/miR‑194‑5p axis regulates cell proliferation and mobility of gastric cancer through suppressing epithelial‑mesenchymal transition
- (2018) Ruqiong Wei et al. Oncology Letters
- Circ_0078767 suppresses non-small-cell lung cancer by protecting RASSF1A expression via sponging miR-330-3p
- (2018) Ting Chen et al. CELL PROLIFERATION
- CircRNA has_circ_0078710 acts as the sponge of microRNA-31 involved in hepatocellular carcinoma progression
- (2018) Binhui Xie et al. GENE
- CircRNA: functions and properties of a novel potential biomarker for cancer
- (2017) Shujuan Meng et al. Molecular Cancer
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- miR-155-5p antagonizes the apoptotic effect of bufalin in triple-negative breast cancer cells
- (2016) Qian Wang et al. ANTI-CANCER DRUGS
- Immunotherapy for lung cancer
- (2016) Antonius Steven et al. RESPIROLOGY
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
- (2015) S. P. Patel et al. MOLECULAR CANCER THERAPEUTICS
- Development of PD-1/PD-L1 Pathway in Tumor Immune Microenvironment and Treatment for Non-Small Cell Lung Cancer
- (2015) Jiabei He et al. Scientific Reports
- Abstract B290: Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors.
- (2014) E. A. Akbay et al. MOLECULAR CANCER THERAPEUTICS
- High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation
- (2010) Chuan-Yong Mu et al. MEDICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started